Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing Lungs

Diagnostic Molecular Pathology

Volumn 16, Issue 2, 2007, Pages 87-90

  Gradowski, Joel F ^a   Mantha, Geeta S ^a   Hunt, Jennifer L ^b   Dacic, Sanja ^a,c  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Atypical adenomatous hyperplasia; Genotype; Lung adenocarcinoma

Indexed keywords

ADENOMA; ADULT; AGED; ARTICLE; CHROMOSOME 10Q; CHROMOSOME 17P; CHROMOSOME 3P; CHROMOSOME 5Q; CHROMOSOME 7P; CHROMOSOME 9P; CLINICAL ARTICLE; COMPARATIVE STUDY; DNA SEQUENCE; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; LUNG CANCER; MALE; MICROSATELLITE MARKER; MOLECULAR BIOLOGY; ONCOGENE K RAS; PRIORITY JOURNAL; SMOKING; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; ADENOMATOSIS; GENETIC MARKER; GENETICS; LUNG; LUNG TUMOR; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRECANCER;

DNA; MICROSATELLITE DNA;

ADENOCARCINOMA; ADENOMATOSIS, PULMONARY; ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; LUNG; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PRECANCEROUS CONDITIONS;

EID: 34347388026     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/PDM.0b013e318030afde     Document Type: Article

References (30)

1. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer. 1995;75(1 suppl):191-202.
2. Miller RR. Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: a clinicopathological study of 10 cases. Thorax. 1993;48:679-680.
3. Kitamura H, Kamadeva Y, lto T, et al. Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. Am J Clin Pathol. 1999;111:610-622.
4. Yokose T, Ito Y, Ochiai A. High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasms. Lung Cancer. 2000;29:125-130.
5. Sterner DJ, Mori M, Roggli VI, et al. Prevalence of pulmonary atypical alveolar cell hyperplasia in an autopsy population: a study of 100 cases. Mod Pathol. 1997;10:469-473.
6. Yokose T, Doi M, Tanno K, et al. Atypical adenomatous hyperplasia of the lung in autopsy cases. Lung Cancer. 2001;33:155-161.
7. Westra WH, Baas IO, Hruban RH, et al. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res. 1996;56:2224-2228.
8. Sagawa M, Saito Y, Fujimura S, et al. K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer. Br J Cancer. 1998;77:720-723.
9. Takamochi K, Ogura T, Suzuki K, et al. Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung. Am J Pathol. 2001;159:1941-1948.
10. Kohno H, Hiroshima K, Toyozaki T, et al. p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma. Cancer. 1999;85:341-347.
11. Slebos RJ, Baas IO, Clement MJ, et al. p53 alterations in atypical alveolar hyperplasia of the human lung. Hum Pathol. 1998;29:801-808.
12. Dacic S, Finkelstein SD, Sasatomi E, et al. Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping. Am J Surg Pathol. 2002;26:510-516.
13. Baksh FK, Dacic S, Finkelstein SD, et al. Widespread molecular alterations present in stage I non-small cell lung carcinoma fail to predict tumor recurrence. Mod Pathol. 2003;16:28-34.
14. Miller RR, Nelems B, Evans KG, et al. Glandular neoplasia of the lung. A proposed analogy to colonic tumors. Cancer. 1988;61:1009-1014.
15. Miller RR. Bronchioloalveolar cell adenomas. Am J Surg Pathol. 1990;14:904-912.
16. Chapman AD, Kerr KM. The association between atypical adenomatous hyperplasia and primary lung cancer. Br J Cancer. 2000;83:632-636.
17. Mori M, Rao SK, Popper HH, et al. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung. Mod Pathol. 2001;14:72-84.
18. Kitamura H, Kameda Y, Nakamura N, et al. Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. Am J Surg Pathol. 1996;20:553-562.
19. Nakayama H, Noguchi M, Tsuchiya R, et al. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content. Mod Pathol. 1990;3:314-320.
20. Kitamura H, Kameda Y, Nakamura N, et al. Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma. Am J Pathol. 1995;146:876-887.
21. Kerr KM, Carey FA, King G, et al. Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression. J Pathol. 1994;174:249-256.
22. Yamasaki M, Takeshima Y, Fujii S, et al. Correlation between genetic alterations and histopathological subtypes in bronchioloalveolar carcinoma and atypical adenomatous hyperplasia of the lung. Pathol Int. 2000;50:778-785.
23. Mori M, Kaji M, Tezuka F, et al. Comparative ultrastructural study of atypical adenomatous hyperplasia and adenocarcinoma of the human lung. Ultrastruct Pathol. 1998;22:459-466.
24. Suzuki K, Nagai K, Yoshida J, et al. The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis. Cancer. 1997;79:1521-1526.
25. Ruffini E, Bongiovanni M, Cavallo A, et al. The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms. Eur J Cardiothorac Surg. 2004;26:165-172.
26. Croce CM, Sozzi G, Huebner K. Role of FHIT in human cancer. J Clin Oncol. 1999;17:1618-1624.
27. Kerr KM, MacKenzie SJ, Ramasami S, et al. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma. J Pathol. 2004;203:638-644.
28. Wistuba II, Lam S, Behrens C, et al. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst. 1997;89:1366-1373.
29. Sozzi G, Pastorino U, Moiraghi I, et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res. 1998;58:5032-5037.
30. Tsuchiya E, Furuta R, Wada N, et al. High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs. J Cancer Res Clin Oncol. 1995;121:577-581.